Epoetin-associated pure red cell aplasia: Past, present, and future considerations

INIS

• patients 100%
• antibodies 60%
• manufacturers 60%
• erythropoietin 60%
• data 40%
• information 40%
• administration 40%
• food and drug administration 40%
• europe 40%
• etiology 40%
• canada 40%
• australia 40%
• human serum albumin 40%
• design 20%
• safety 20%
• toxicity 20%
• anemias 20%
• asia 20%
• coatings 20%
• rubbers 20%
• singapore 20%
• teflon 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Recombinant Erythropoietin 100%
• Pure Red Cell Anemia 100%
• Antibody 25%
• Erythropoietin 25%
• Hemodialysis 25%
• Etiology 16%
• Human Serum Albumin 16%
• Anemia 8%
• Politef 8%
• Rubber 8%
• Incidence 8%
• Toxicity Class 8%